Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China · Delayed Price · Currency is CNY 24.97
+0.46 (1.88%)
At close: Jul 15, 2026
SHE:301258 Market Cap
SHE:301258 has a market cap or net worth of 2.17 billion as of July 15, 2026. Its market cap has decreased by -19.37% in one year.
Market Cap
2.17B
Enterprise Value
1.01B
Revenue
412.51M
Ranking
n/a
PE Ratio
58.70
Stock Price
24.97
Market Cap Chart
Since March 29, 2022, SHE:301258's market cap has decreased from 6.10B to 2.17B, a decrease of -64.39%. That is a compound annual growth rate of -21.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 2.17B | -25.50% |
| Dec 31, 2025 | 2.91B | 35.37% |
| Dec 31, 2024 | 2.15B | -27.24% |
| Dec 29, 2023 | 2.96B | -17.76% |
| Dec 30, 2022 | 3.60B | -41.00% |
| Mar 29, 2022 | 6.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yantai Zhenghai Biotechnology | 2.62B |
| Landfar Bio-medicine | 2.55B |
| Shenzhen Bioeasy Biotechnology | 2.53B |
| Shanghai Universal Biotech | 2.34B |
| Shandong Sito Bio-technology | 2.30B |
| Jilin Jian Yisheng Pharmaceutical | 2.16B |
| Jiangsu Gdk Biological Technology | 1.90B |
| Shanghai Hile Bio-Technology | 1.88B |